ghk-cu vs bpc-157 & Peptides: The Truth Revealed BPC-157 Research Peptide | BPC-157
Description
No pharmaceutical company has initiated FDA clinical trials for BPC-157
Ilic et al., 2011a), duodenum (Sikiric et al., 1994
Healthy volunteers were given thymosin 4 by infusion, tolerated it well, and showed no serious adverse effects
A recent endoscopy shows a gastric ulcer with active bleeding
